European cancer mortality predictions for the year 2016 with focus on leukaemias, Annals of Oncology, vol.27, issue.4, pp.27-725, 2016. ,
DOI : 10.1093/annonc/mdw022
Cancer statistics, 2016, Cancer statistics, pp.7-30, 2016. ,
DOI : 10.1111/obr.12321
Treatment options in hormonerefractory metastatic prostate carcinoma, Tumori, vol.90, pp.535-546, 2004. ,
Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer, New England Journal of Medicine, vol.351, issue.15, pp.351-1513, 2004. ,
DOI : 10.1056/NEJMoa041318
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer, New England Journal of Medicine, vol.351, issue.15, pp.351-1502, 2004. ,
DOI : 10.1056/NEJMoa040720
Initial Biopsy Gleason Score as a Predictive Marker for Survival Benefit in Patients with Castration-resistant Prostate Cancer Treated with Docetaxel: Data from the TAX327 Study, European Urology, vol.66, issue.2, pp.66-330, 2014. ,
DOI : 10.1016/j.eururo.2013.08.007
Targeting TCTP as a New Therapeutic Strategy in Castration-resistant Prostate Cancer, Molecular Therapy, vol.20, issue.12, pp.2244-2256, 2012. ,
DOI : 10.1038/mt.2012.155
Gene silencing of translationally controlled tumor protein (TCTP) by siRNA inhibits cell growth and induces apoptosis of human prostate cancer cells, International Journal of Oncology, pp.34-1241, 2009. ,
DOI : 10.3892/ijo_00000252
TCTP Is an Androgen-Regulated Gene Implicated in Prostate Cancer, PLoS ONE, vol.105, issue.7, p.69398, 2013. ,
DOI : 10.1371/journal.pone.0069398.g007
Translationally Controlled Tumor Protein in Prostatic Adenocarcinoma: Correlation with Tumor Grading and Treatment-Related Changes, BioMed Research International, vol.59, pp.2015-985950, 2015. ,
DOI : 10.1186/1746-1596-7-90
TCTP as therapeutic target in cancers, Cancer Treatment Reviews, vol.40, issue.6, pp.760-769, 2014. ,
DOI : 10.1016/j.ctrv.2014.02.007
The translationally controlled tumour protein (TCTP), The International Journal of Biochemistry & Cell Biology, vol.36, issue.3, pp.379-385, 2004. ,
DOI : 10.1016/S1357-2725(03)00213-9
Potential role of histamine releasing factor (HRF) as a therapeutic target for treating asthma and allergy, Journal of Asthma and Allergy, vol.5, pp.51-59, 2012. ,
DOI : 10.2147/JAA.S28868
Molecular identification of an IgE-dependent histamine-releasing factor, Science, vol.269, issue.5224, pp.688-690, 1995. ,
DOI : 10.1126/science.7542803
Biological Effects of Mammalian Translationally Controlled Tumor Protein (TCTP) on Cell Death, Proliferation, and Tumorigenesis, Biochemistry Research International, vol.112, issue.8, p.2012, 2012. ,
DOI : 10.1074/jbc.M109.012823
TPT1/ TCTP-regulated pathways in phenotypic reprogramming, Trends in Cell Biology, vol.23, issue.1, pp.37-46, 2013. ,
DOI : 10.1016/j.tcb.2012.10.002
URL : http://hdl.handle.net/2434/213480
Translationally controlled tumor protein is a target of tumor reversion, Proceedings of the National Academy of Sciences, vol.16, issue.16, pp.15364-15369, 2004. ,
DOI : 10.1038/sj.onc.1201729
Therapeutic antisense oligonucleotides against cancer: hurdling to the clinic, Frontiers in Chemistry, vol.18, issue.83, 2014. ,
DOI : 10.1038/gt.2010.133
URL : http://doi.org/10.3389/fchem.2014.00087
Silencing disease genes in the laboratory and the clinic, The Journal of Pathology, vol.70, issue.2, pp.365-379, 2012. ,
DOI : 10.1002/path.2993
Oligonucleotide conjugates for therapeutic applications, Therapeutic Delivery, vol.4, issue.7, pp.791-809, 2013. ,
DOI : 10.4155/tde.13.47
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787477
Enhanced Downregulation of the p75 Nerve Growth Factor Receptor by Cholesteryl and Bis-Cholesteryl Antisense Oligonucleotides, Antisense and Nucleic Acid Drug Development, vol.8, issue.6, pp.489-498, 1998. ,
DOI : 10.1089/oli.1.1998.8.489
Lipid-Conjugated Oligonucleotides via ???Click Chemistry??? Efficiently Inhibit Hepatitis C Virus Translation, Journal of Medicinal Chemistry, vol.51, issue.15, pp.51-4374, 2008. ,
DOI : 10.1021/jm800518u
Perfluoroalkylchain conjugation as a new tactic for enhancing cell permeability of peptide nucleic acids (PNAs) via reducing the nanoparticle size, Chem. Commun., vol.3, issue.3, pp.52-521, 2016. ,
DOI : 10.1039/C5CC05342K
Fluorocarbon oligonucleotide conjugates for nucleic acids delivery, MedChemComm, vol.31, issue.1, pp.76-78, 2010. ,
DOI : 10.1039/c0md00054j
Quantum Dot Lipid Oligonucleotide Bioconjugates: Toward a New Anti-MicroRNA Nanoplatform, Bioconjugate Chemistry, vol.24, issue.8, pp.24-1345, 2013. ,
DOI : 10.1021/bc400157z
Sensitive liposomes encoded with oligonucleotide amphiphiles: a biocompatible switch, Chemical Communications, vol.27, issue.43, pp.5550-5552, 2008. ,
DOI : 10.1039/b812398e
Lipid oligonucleotide conjugates as responsive nanomaterials for drug delivery, Journal of Materials Chemistry B, vol.40, issue.39, pp.5329-5334, 2013. ,
DOI : 10.1039/c3tb20357c
Characterization of Fortilin, a Novel Antiapoptotic Protein, Journal of Biological Chemistry, vol.276, issue.50, pp.47542-47549, 2001. ,
DOI : 10.1074/jbc.M108954200
Biological models and genes of tumor reversion: Cellular reprogramming through tpt1/TCTP and SIAH-1, Proceedings of the National Academy of Sciences, vol.276, issue.50, pp.99-14976, 2002. ,
DOI : 10.1074/jbc.M108954200
Translationally controlled tumor protein (TCTP) in the human prostate and prostate cancer cells: Expression, distribution, and calcium binding activity, The Prostate, vol.2, issue.3, pp.130-140, 2004. ,
DOI : 10.1002/pros.20054
Somatostatin effects on the proteome of the LNCaP cell-line, International Journal of Oncology, pp.30-1173, 2007. ,
DOI : 10.3892/ijo.30.5.1173
Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides, Mol. Pharmacol, pp.41-1023, 1992. ,
Transformed and immortalized cellular uptake of oligodeoxynucleoside phosphorothioates, 3???-Alkylamino oligodeoxynucleotides, 2???-o-methyl oligoribonucleotides, oligodeoxynucleoside methylphosphonates, and peptide nucleic acids, Biochemical Pharmacology, vol.53, issue.10, pp.53-1465, 1997. ,
DOI : 10.1016/S0006-2952(97)82440-9
Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents, Nucleic Acids Research, vol.38, issue.1, p.3, 2010. ,
DOI : 10.1093/nar/gkp841
Characterization of oligonucleotide transport into living cells., Proceedings of the National Academy of Sciences, vol.86, issue.10, pp.86-3474, 1989. ,
DOI : 10.1073/pnas.86.10.3474
Mechanism of oligonucleotide uptake by cells: involvement of specific receptors?, Proceedings of the National Academy of Sciences, vol.86, issue.17, pp.86-6454, 1989. ,
DOI : 10.1073/pnas.86.17.6454
Mechanisms of single-stranded phosphorothioate modified antisense oligonucleotide accumulation in hepatocytes, Nucleic Acids Research, vol.39, issue.11, pp.4795-4807, 2011. ,
DOI : 10.1093/nar/gkr089
Mechanisms and optimization of in vivo delivery of lipophilic siRNAs, Nature Biotechnology, vol.409, issue.10, pp.25-1149, 2007. ,
DOI : 10.1038/nbt1339
Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown, Nature Biotechnology, vol.33, issue.8, pp.33-870, 2015. ,
DOI : 10.1172/JCI200215420
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663660
Role of Translationally Controlled Tumor Protein in Cancer Progression, Biochemistry Research International, vol.2, issue.1, p.2012, 2012. ,
DOI : 10.1002/1522-2683(20000801)21:14<3048::AID-ELPS3048>3.0.CO;2-W
A Knockout Mouse Approach Reveals that TCTP Functions as an Essential Factor for Cell Proliferation and Survival in a Tissue- or Cell Type-specific Manner, Molecular Biology of the Cell, vol.18, issue.7, pp.2525-2532, 2007. ,
DOI : 10.1091/mbc.E07-02-0188
Short Antisense Oligonucleotides with Novel 2??????4??? Conformationaly Restricted Nucleoside Analogues Show Improved Potency without Increased Toxicity in Animals, Journal of Medicinal Chemistry, vol.52, issue.1, pp.52-62, 2009. ,
DOI : 10.1021/jm801294h
Chemical modification study of antisense gapmers, Nucleic Acid Ther, pp.22-344, 2012. ,
Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animals, Nucleic Acids Research, vol.35, issue.2, pp.687-700, 2007. ,
DOI : 10.1093/nar/gkl1071
URL : http://doi.org/10.1093/nar/gkl1071
Lipid-oligonucleotide conjugates improve cellular uptake and efficiency of TCTP-antisense in castration-resistant prostate cancer, Journal of Controlled Release, vol.258, pp.1-9, 2017. ,
DOI : 10.1016/j.jconrel.2017.04.042
URL : https://hal.archives-ouvertes.fr/inserm-01520102